| Primary |
| Hiv Infection |
20.1% |
| Asthma |
17.1% |
| Chronic Obstructive Pulmonary Disease |
7.9% |
| Seasonal Allergy |
6.1% |
| Sinusitis |
5.5% |
| Hypersensitivity |
4.9% |
| Rhinitis Allergic |
4.9% |
| Drug Use For Unknown Indication |
3.7% |
| Multiple Allergies |
3.7% |
| Type 2 Diabetes Mellitus |
3.7% |
| Acquired Immunodeficiency Syndrome |
3.0% |
| Bronchospasm |
2.4% |
| Cushing's Syndrome |
2.4% |
| Hypertension |
2.4% |
| Prophylaxis |
2.4% |
| Rhinitis |
2.4% |
| Dyspnoea |
1.8% |
| Nasal Congestion |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Rash |
1.8% |
|
| Product Quality Issue |
26.0% |
| Sinusitis |
13.0% |
| Drug Ineffective |
7.8% |
| Headache |
5.2% |
| Weight Increased |
5.2% |
| Dyspnoea Exacerbated |
3.9% |
| Epistaxis |
3.9% |
| Product Odour Abnormal |
3.9% |
| Adrenal Insufficiency |
2.6% |
| Cushing's Syndrome |
2.6% |
| Diarrhoea |
2.6% |
| Dysgeusia |
2.6% |
| Gastric Ulcer |
2.6% |
| Nasal Discomfort |
2.6% |
| Osteoporosis |
2.6% |
| Petit Mal Epilepsy |
2.6% |
| Rash |
2.6% |
| Rhinalgia |
2.6% |
| Sneezing |
2.6% |
| Suicide Attempt |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
52.9% |
| Chronic Obstructive Pulmonary Disease |
8.4% |
| Hypertension |
6.7% |
| Asthma |
5.8% |
| Drug Use For Unknown Indication |
4.9% |
| Hiv Infection |
3.2% |
| Bronchitis |
2.1% |
| Bronchopulmonary Aspergillosis Allergic |
1.8% |
| Menopausal Symptoms |
1.7% |
| Sinusitis |
1.5% |
| Muscle Spasms |
1.4% |
| Cystic Fibrosis |
1.2% |
| Fibromyalgia |
1.2% |
| Hypersensitivity |
1.2% |
| Pneumonia |
1.2% |
| Multiple Allergies |
1.1% |
| Sinus Disorder |
1.1% |
| Wheezing |
1.1% |
| Rhinovirus Infection |
0.9% |
| Seasonal Allergy |
0.8% |
|
| Drug Interaction |
11.9% |
| Vestibular Disorder |
10.2% |
| Nightmare |
8.5% |
| Polymedication |
6.8% |
| Cushing's Syndrome |
5.1% |
| Drug Ineffective |
5.1% |
| Infection |
5.1% |
| Pyrexia |
5.1% |
| Weight Increased |
5.1% |
| Asthmatic Crisis |
3.4% |
| Death |
3.4% |
| Educational Problem |
3.4% |
| Faeces Discoloured |
3.4% |
| Lung Infection |
3.4% |
| Nasal Congestion |
3.4% |
| Off Label Use |
3.4% |
| Parosmia |
3.4% |
| Pruritus |
3.4% |
| Secondary Adrenocortical Insufficiency |
3.4% |
| Tendonitis |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.6% |
| Drug Use For Unknown Indication |
12.8% |
| Asthma |
7.5% |
| Hypertension |
4.7% |
| Hypersensitivity |
3.9% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Pain |
3.7% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Rheumatoid Arthritis |
2.7% |
| Depression |
2.6% |
| Anxiety |
2.0% |
| Diabetes Mellitus |
1.9% |
| Crohn's Disease |
1.8% |
| Osteoporosis |
1.8% |
| Blood Cholesterol Increased |
1.5% |
| Smoking Cessation Therapy |
1.4% |
| Atrial Fibrillation |
1.4% |
| Prophylaxis |
1.4% |
| Nausea |
1.4% |
| Cardiac Disorder |
1.2% |
|
| Vomiting |
10.4% |
| Weight Decreased |
7.3% |
| Drug Ineffective |
7.1% |
| Tremor |
6.7% |
| Pulmonary Embolism |
6.1% |
| Weight Increased |
6.1% |
| Pain |
5.5% |
| Sinusitis |
4.9% |
| Ventricular Tachycardia |
4.7% |
| Pneumonia |
4.5% |
| Pyrexia |
4.3% |
| Urinary Tract Infection |
4.3% |
| Product Quality Issue |
4.1% |
| Wheezing |
4.1% |
| Nausea |
3.9% |
| Vision Blurred |
3.5% |
| Asthma |
3.3% |
| Rash |
3.1% |
| Renal Failure Acute |
3.1% |
| Sepsis |
3.1% |
|
| Interacting |
| Cystic Fibrosis |
24.8% |
| Hiv Infection |
18.6% |
| Drug Use For Unknown Indication |
11.0% |
| Asthma |
6.9% |
| Bronchopulmonary Aspergillosis Allergic |
6.2% |
| Product Used For Unknown Indication |
5.5% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Depression |
3.4% |
| Aspergillus Infection |
2.1% |
| Hepatitis B |
2.1% |
| Hypertension |
2.1% |
| Pruritus |
2.1% |
| Bronchitis Chronic |
1.4% |
| Dyspnoea |
1.4% |
| Hiv Wasting Syndrome |
1.4% |
| Nasal Congestion |
1.4% |
| Obstructive Airways Disorder |
1.4% |
| Oral Candidiasis |
1.4% |
| Oropharyngeal Candidiasis |
1.4% |
| Rheumatoid Arthritis |
1.4% |
|
| Drug Interaction |
35.1% |
| Pituitary-dependent Cushing's Syndrome |
10.8% |
| Hepatitis B |
5.4% |
| Hypothalamic Pituitary Adrenal Axis Suppression |
5.4% |
| Kaposi's Sarcoma |
5.4% |
| Secondary Adrenocortical Insufficiency |
5.4% |
| Steroid Withdrawal Syndrome |
5.4% |
| Hyponatraemia |
2.7% |
| Isolated Adrenocorticotropic Hormone Deficiency |
2.7% |
| Kaposi's Sarcoma Aids Related |
2.7% |
| Osteoporotic Fracture |
2.7% |
| Suicide Attempt |
2.7% |
| Swelling |
2.7% |
| Unevaluable Event |
2.7% |
| Urticaria |
2.7% |
| Weight Decreased |
2.7% |
| Weight Increased |
2.7% |
|
